Fungal keratitis in Melbourne

Clinical and Experimental Ophthalmology

Volumn 35, Issue 2, 2007, Pages 124-130

  Bhartiya, Prashant ^a,b   Daniell, Mark ^a,b   Constantinou, Marios ^a,b   Islam, F M Amirul ^a,b   Taylor, Hugh R ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

Antifungal drug; Candida albicans; Fungal keratitis; Voriconazole

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIGLAUCOMA AGENT; CIPROFLOXACIN; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; NATAMYCIN; OFLOXACIN; PREDNISOLONE; PROXYMETACAINE; STEROID; TERBINAFINE; TOBRAMYCIN; VORICONAZOLE;

ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; AUSTRALIA; CANDIDA ALBICANS; CLINICAL FEATURE; CONTROLLED STUDY; CORNEA; CORNEA PERFORATION; DRUG TREATMENT FAILURE; EVISCERATION; EYE INJURY; FEMALE; FOLLOW UP; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; FUSARIUM; HUMAN; INCIDENCE; INFECTION RISK; KERATOMYCOSIS; KERATOPLASTY; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CHILD; CORNEAL ULCER; EYE EVISCERATION; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIUM; HOSPITALS, SPECIAL; HUMANS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; OPHTHALMOLOGY; RETROSPECTIVE STUDIES; RISK FACTORS; VICTORIA;

EID: 33847775352     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01405.x     Document Type: Article

References (28)

1. Srinivasan M, Gonzales CA, George C et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997; 81: 965-71.
2. Upadhyay MP, Karmacharya PCD, Koirala S et al. Epidemiological characteristics, predisposing factors and aetiological diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991; 111: 92-9.
3. Dunlop AA, Wright ED, Howlader SA et al. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol 1994; 22: 105-10.
4. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980; 90: 38-47.
5. Mino de Kaspar H, Zoulek G, Paredes ME et al. Mycotic keratitis in Paraguay. Mycoses 1991; 34: 251-4.
6. Leck AK, Thomas PA, Hagan M et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002; 86: 1211-15.
7. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000; 19: 307-12.
8. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South India. Cornea 2002; 21: 555-9.
9. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 2003; 51: 315-21.
10. Laspina F, Samudio M, Cibils D et al. Epidemiological characteristics of microbiological results on patients with infectious corneal ulcers: A 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004; 242: 204-9.
11. Doughman DJ, Leavenworth NM, Campbell RC, Lindstrom RL. Fungal keratitis at the University of Minnesota: 1971-1981. Trans Am Ophthalmol Soc 1982; 80: 235-47.
12. Ross HW, Laibson PR. Keratomycosis. Am J Ophthalmol 1972; 74: 438-41.
13. Chowdhary A, Singh K. Spectrum of fungal keratitis in north India. Cornea 2005; 24: 8-15.
14. Houang E, Lam D, Fan D, Seal D. Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection. Trans R Soc Trop Med Hyg 2001; 95: 361-7.
15. Wilhelmus KR, Robinson NM, Font RA, Hamill MB, Jones DB. Fungal keratitis in contact lens wearers. Am J Ophthalmol 1988; 106: 708-14.
16. Mitsui Y, Hanabusa J. Corneal infections after cortisone therapy. Br J Ophthalmol 1955; 39: 244-50.
17. Berson EL, Kobayashi GS, Becker B, Rosenbaum L. Topical corticosteroids and fungal keratitis. Invest Ophthalmol 1967; 6: 512-17.
18. Bell NP, Karp CL, Alfonso EC et al. Effects of methyl prednisolone and cyclosporin A on fungal growth in vitro. Cornea 1999; 18: 306-13.
19. Arentsen JJ, Laibson PR, Cohen EJ. Management of corneal descemetoceles and perforations. Ophthalmic Surg 1985; 16: 29-33.
20. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994; 101: 1005-13.
21. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 15: 321-7.
22. Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther 2003; 25: 1321-81.
23. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004; 137: 820-5.
24. Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea 2003; 22: 33-6.
25. Anderson KL, Mitra S, Salouti R, Pham TA, Taylor HR. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea 2004; 23: 516-21.
26. Zhou L, Glickman RD, Chen N, Sponsel WE, Graybill JR, Lam KW. Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 776: 213-20.
27. Hariprasad SM, Mieler WF, Holz ER et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004; 122: 42-7.
28. Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents: Pharmacokinetics, safety and efficacy. Drugs 2004; 64: 1997-2020.